BioHealth News Archive
Altimmune, Inc. (Nasdaq: ALT) to Ring The Nasdaq Stock Market Opening Bell – NASDAQ.com
Altimmune, Inc. (Nasdaq:ALT), a clinical stage immunotherapeutic biotechnology company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Bill Enright,…
Read More
Altimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases Nasdaq:ALT
Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the…
Read More
Hospital Impact: Congress must learn from the past and avoid undermining medical research – FierceHealthcare
What's the definition of "doing the same thing repeatedly and expecting a different result?" If you said "a good idea," you might want to…
Read More
Greater Washington Partnership Expands Board of Directors
The Greater Washington Partnership (Partnership), a group of leading CEOs and entrepreneurs aimed at addressing the critical economic issues facing the Greater Washington region,…
Read More
Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufacturing in Baltimore NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon-cutting ceremony led by Dr. Rick Bright, director of the Biomedical Advanced Research and Development Authority (BARDA),…
Read More
Federal Labs: New Class of FLC Officers Elected at 2017 National Meeting
During the 2017 FLC national meeting in San Antonio, Texas, the FLC held its annual elections for open positions to serve on the Executive…
Read MoreThe long shot: How the region wants to become a top three biotech market by 2023
Business leaders hope to elevate Greater Washington to top three biotech clusters in U.S. Yeah, good luck. {iframe}http://www.bizjournals.com/washington/news/2017/05/12/the-long-shot-how-the-region-wants-to-become-a-top.html{/iframe}
Read MoreAltimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases
GAITHERSBURG, Md., May 04, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4,…
Read MoreAltimmune, Inc. (Nasdaq: ALT) to Ring The Nasdaq Stock Market Opening Bell
What: Altimmune, Inc. (Nasdaq: ALT), a clinical stage immunotherapeutic biotechnology company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion,…
Read More
2017 Pharmaceuticals and Life Sciences Trends
Pharmaceuticals and life sciences companies are experiencing a wave of competing challenges as part of what could be called the New Health Economy. They…
Read More
$17 Million Available to Spur Regional Innovation – GRANTS.GOV
The U.S. Department of Commerce’s Economic Development Administration (EDA) today published the Notice of Funding Availability (NOFA) for its 2017 Regional Innovations Strategies (RIS)…
Read More
Advancing Science and Accelerating Innovation in the BioHealth Capital Region
Collaboration across academia, government, non-profits, and the biopharmaceutical industry fosters innovation and groundbreaking discoveries in science and research. During the 2017 BioHealth Capital Region…
Read More
Emergent BioSolutions doubles capacity at Baltimore plant – FiercePharma
Emergent BioSolutions is one of the vaccine producers that the federal government can tap in case of a virus pandemic, and now it has…
Read More
VLP Therapeutics Announces Convertible Note Investment from TomyK Ltd. for Accelerating Cancer Vaccine Development – VLP Therapeutics
VLP Therapeutics, LLC (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and antibody agents, today announced that…
Read More
Emergent BioSolutions opens expanded East Baltimore vaccine plant – Baltimore Sun
When the next flu pandemic strikes or, perish the thought, the Ebola virus starts spreading in the United States, a newly expanded pharmaceutical plant…
Read More